273 related articles for article (PubMed ID: 1829642)
1. Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts.
Van Weely S; Van Leeuwen MB; Jansen ID; De Bruijn MA; Brouwer-Kelder EM; Schram AW; Sa Miranda MC; Barranger JA; Petersen EM; Goldblatt J
Biochim Biophys Acta; 1991 Jun; 1096(4):301-11. PubMed ID: 1829642
[TBL] [Abstract][Full Text] [Related]
2. Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease.
Meivar-Levy I; Horowitz M; Futerman AH
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):377-82. PubMed ID: 7980395
[TBL] [Abstract][Full Text] [Related]
3. Comparative study on glucocerebrosidase in spleens from patients with Gaucher disease.
Aerts JM; Donker-Koopman WE; Brul S; Van Weely S; Sa Miranda MC; Barranger JA; Tager JM; Schram AW
Biochem J; 1990 Jul; 269(1):93-100. PubMed ID: 2198026
[TBL] [Abstract][Full Text] [Related]
4. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.
van Weely S; van den Berg M; Barranger JA; Sa Miranda MC; Tager JM; Aerts JM
J Clin Invest; 1993 Mar; 91(3):1167-75. PubMed ID: 8450045
[TBL] [Abstract][Full Text] [Related]
5. Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients.
Sa Miranda MC; Aerts JM; Pinto R; Fontes A; de Lacerda LW; van Weely S; Barranger J; Tager JM
Clin Genet; 1990 Sep; 38(3):218-27. PubMed ID: 2225530
[TBL] [Abstract][Full Text] [Related]
6. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
Choy FY
Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
[TBL] [Abstract][Full Text] [Related]
7. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
8. Characterization of glucocerebrosidase in Greek Gaucher disease patients: mutation analysis and biochemical studies.
Michelakakis H; Dimitriou E; Van Weely S; Boot RG; Mavridou I; Verhoek M; Aerts JM
J Inherit Metab Dis; 1995; 18(5):609-15. PubMed ID: 8598642
[TBL] [Abstract][Full Text] [Related]
9. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.
Ginns EI; Brady RO; Pirruccello S; Moore C; Sorrell S; Furbish FS; Murray GJ; Tager J; Barranger JA
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5607-10. PubMed ID: 6957882
[TBL] [Abstract][Full Text] [Related]
10. Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease.
Serra-Vinardell J; Díaz L; Gutiérrez-de Terán H; Sánchez-Ollé G; Bujons J; Michelakakis H; Mavridou I; Aerts JM; Delgado A; Grinberg D; Vilageliu L; Casas J
Int J Biochem Cell Biol; 2014 Sep; 54():245-54. PubMed ID: 25084554
[TBL] [Abstract][Full Text] [Related]
11. Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase.
Van Weely S; Aerts JM; Van Leeuwen MB; Heikoop JC; Donker-Koopman WE; Barranger JA; Tager JM; Schram AW
Eur J Biochem; 1990 Aug; 191(3):669-77. PubMed ID: 2143986
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts.
Jonsson LM; Murray GJ; Sorrell SH; Strijland A; Aerts JF; Ginns EI; Barranger JA; Tager JM; Schram AW
Eur J Biochem; 1987 Apr; 164(1):171-9. PubMed ID: 3549301
[TBL] [Abstract][Full Text] [Related]
13. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
McNeill A; Magalhaes J; Shen C; Chau KY; Hughes D; Mehta A; Foltynie T; Cooper JM; Abramov AY; Gegg M; Schapira AH
Brain; 2014 May; 137(Pt 5):1481-95. PubMed ID: 24574503
[TBL] [Abstract][Full Text] [Related]
14. Conditions affecting the activity of glucocerebrosidase purified from spleens of control subjects and patients with type 1 Gaucher disease.
Aerts JM; Sa Miranda MC; Brouwer-Kelder EM; Van Weely S; Barranger JA; Tager JM
Biochim Biophys Acta; 1990 Oct; 1041(1):55-63. PubMed ID: 2223847
[TBL] [Abstract][Full Text] [Related]
15. Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues.
Choy FY
Am J Med Genet; 1985 Jul; 21(3):519-28. PubMed ID: 4025386
[TBL] [Abstract][Full Text] [Related]
16. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity.
Ron I; Horowitz M
Hum Mol Genet; 2005 Aug; 14(16):2387-98. PubMed ID: 16000318
[TBL] [Abstract][Full Text] [Related]
17. Retrovirus-mediated transfer of the human glucocerebrosidase gene to Gaucher fibroblasts.
Choudary PV; Barranger JA; Tsuji S; Mayor J; LaMarca ME; Cepko CL; Mulligan RC; Ginns EI
Mol Biol Med; 1986 Jun; 3(3):293-9. PubMed ID: 3736391
[TBL] [Abstract][Full Text] [Related]
18. Electrophoresis of glucocerebrosidase from normal and Gaucher disease fibroblasts.
Dale GL; Gudas J; Woloszyn W; Beutler E
Am J Hum Genet; 1979 Jul; 31(4):518-21. PubMed ID: 484554
[TBL] [Abstract][Full Text] [Related]
19. Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells.
Siebert M; Westbroek W; Chen YC; Moaven N; Li Y; Velayati A; Saraiva-Pereira ML; Martin SE; Sidransky E
RNA Biol; 2014; 11(10):1291-300. PubMed ID: 25584808
[TBL] [Abstract][Full Text] [Related]
20. Presence of activator proteins for the enzymatic degradation of glucosylceramide in several human tissues.
Vaccaro AM; Ciaffoni F; Mandara I; Suzuki K
Clin Chim Acta; 1988 Mar; 172(2-3):323-34. PubMed ID: 3370844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
